-
Sector Analysis
China Baby Food Market Size and Share by Categories, Distribution and Forecast to 2028
China Baby Food Market Report Overview The China baby food market size was CNY94.8 billion ($14.1 billion) in 2022. The market is expected to garner a CAGR of less than 1% during 2022-2028. China Baby Food Market Outlook, 2022-2028 (CNY Billion) Buy the Full Report for More Insights on the China Baby Food Market Forecast, Download A Free Report Sample The China baby food market research report puts together multiple data sources to provide a comprehensive baby food sector overview...
-
Sector Analysis
Turkey Baby Food Market Size and Share by Categories, Distribution and Forecast to 2028
Turkey Baby Food Market Report Overview The baby food sales in Turkey were TRY2.9 billion in 2022. The Turkey baby food market will garner a CAGR of more than 20% during 2022-2028. The Turkey baby food market outlook includes demographic and socio-economic trends to aid clients in effective decision-making. Turkey Baby Food Market Outlook, 2022-2028 (TRY Billion) Buy the Full Report for Turkey Baby Food Market Revenue, Download A Free Report Sample The Turkey baby food market insights cover current...
-
Sector Analysis
Australia Baby Food Market Size and Share by Categories, Distribution and Forecast to 2028
Australia Baby Food Market Report Overview The baby food sales in Australia were worth AUD508.3 million in 2022. The Australian baby food market will record a CAGR of more than 4% during 2022-2028. The Australia baby food market outlook includes demographic and socio-economic trends to aid clients in effective decision-making. Australia Baby Food Market Outlook, 2022-2028 (AUD Million) Buy Full Report for More Insights on the Australia Baby Food Market Forecast Download A Free Report Sample The Australia baby food market...
-
Company Profile
Oxurion NV – Company Profile
Oxurion NV (Oxurion), formerly ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer therapeutics. The company’s ocriplasmin, a recombinant derivative of the plasmin protein, is commercialized as Jetrea in the US to treat symptomatic vitreomacular adhesion (VMA) and vitreomacular traction (VMT). Oxurion’s product pipeline includes THR-687, a pan-RGD integrin antagonist being developed for the treatment of diabetic retinopathy, and THR-149, a plasma kallikrein inhibitor, for the treatment of diabetic macular edema (DME). It has commercialization agreements...
Add to Basket -
Sector Analysis
Peru Baby Food Market Size by Categories, Distribution Channel, Market Share and Forecast, 2022-2027
Peru Baby Food Market Report Overview The Peru baby food market size valued at PEH877.1 million in 2021. The market will garner a CAGR of less than 2% during 2021-2027. The Peru baby food market outlook includes demographic and socio-economic trends to aid clients in effective decision-making. Peru Baby Food Market Outlook 2021-2027 (PEH Million) Buy the Full Report for the Peru Baby Food Market Revenue, Download PDF Sample The Peru baby food market insights cover current and future trends that...
-
Product Insights
Myasthenia Gravis Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Myasthenia Gravis Global Clinical Trials Review, H1, 2018" provides an overview of Myasthenia Gravis clinical trials scenario. This report provides top line data relating to the clinical trials on Myasthenia Gravis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Mycobacterium Infections Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Mycobacterium Infections Global Clinical Trials Review, H1, 2018" provides an overview of Mycobacterium Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Mycobacterium Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Cigarettes in the Philippines, 2017
"Cigarettes in the Philippines, 2017", is an analytical report by GlobalData that provides extensive and highly detailed current and future market trends in the the Philippine market. It covers market size and structure along with per capita and overall consumption. Additionally, it focuses on brand data, retail pricing, prospects and forecasts for sales and consumption to 2025. The cigarette market in the Philippines is large despite falling back recently. Although legitimate duty paid consumption was reported down by 12.1% to...
-
Product Insights
Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2017" provides an overview of Gram-Positive Bacterial Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Gram-Positive Bacterial Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Obstructive Pulmonary Disease (COPD) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Obstructive Pulmonary Disease (COPD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...